Skip to content

the effects of pemafibrate on epicardia adippose tissue(EAT)

the effects of pemafibrate on epicardia adippose tissue(EAT) - pemafibrate on EAT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036033
Enrollment
15
Registered
2019-04-01
Start date
2019-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with hyperlipidemia

Interventions

None listed

Sponsors

Tokushima Univ
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: hyperlipidemia

Exclusion criteria

Exclusion criteria: pemafibrate not applicable

Design outcomes

Primary

MeasureTime frame
decrease in EAT

Countries

Japan

Contacts

Public ContactShusuke Yagi

The University of Tokushima Graduate School of Health Biosciences Department of Community Medicine and Human Resource Development

syagi@tokushima-u.ac.jp088-633-7851

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026